TrialThe Journal of pediatrics2018

HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease.

Arlene Smaldone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.